Found 17 matching trials
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia PHASE1 This phase IB trial studies the feasibility of using a functional laborator...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia PHASE2 Any time the words "you," "your," "I," or "me" appear, it is meant to apply...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma PHASE2 Phase II trial to study the effectiveness of combining rituximab and rasbur...
Show More Location
Children's Oncology Group
Learn More & Join Trial
Cardiac Safe Transplants for Systemic Sclerosis PHASE2 This study is designed to treat systemic sclerosis (scleroderma) patients w...
Show More Location
Northwestern University, Feinberg School of Medicine
Learn More & Join Trial
Rituximab and Belimumab for Lupus Nephritis PHASE2 In this experimental study, researchers will try to find out if treatment o...
Show More Location
University of Alabama, Birmingham
Learn More & Join Trial
Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT PHASE2 The purpose of this study is to determine if double autologous then allogen...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm PHASE2 This phase II trial studies how well venetoclax, SL-401, and chemotherapy w...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma PHASE2 The purpose of this trial is to develop an alternative treatment for patien...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Trial of Rituximab for Graves' Ophthalmopathy PHASE2 This study is being done to investigate the effects (good and bad) of Ritux...
Show More Learn More & Join Trial
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial